We are live on ! Find out more
Deutsche Bank

Deutsche Bank Portfolio holdings

AUM $303B
1-Year Est. Return 30.15%
 

Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.

This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+30.15%
3 Year Est. Return
+94.64%
5 Year Est. Return
+128.65%
10 Year Est. Return
+466.74%
AUM
$153B
AUM Growth
+$9.45B
Cap. Flow
-$5.3B
Cap. Flow %
-3.45%
Top 10 Hldgs %
17.22%
Holding
5,318
New
407
Increased
2,249
Reduced
1,924
Closed
262

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$333M
2
BABA icon
Alibaba
BABA
+$303M
3
PFE icon
Pfizer
PFE
+$269M
4
MSFT icon
Microsoft
MSFT
+$264M
5
ES icon
Eversource Energy
ES
+$255M

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Healthcare 13.63%
3 Financials 11.69%
4 Communication Services 9.98%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCS
3926
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$38K ﹤0.01%
628
+354
+129% +$22.4K
NBSE
3927
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$38K ﹤0.01%
+271
New +$31.8K
LOGC
3928
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$38K ﹤0.01%
5,503
+3,095
+129% +$28K
PCOM
3929
DELISTED
Points.com Inc. Common Shares
PCOM
$38K ﹤0.01%
2,514
+1,125
+81% +$13.9K
STND
3930
DELISTED
Standard AVB Financial Corp. Common Stock
STND
$38K ﹤0.01%
1,286
AKRO
3931
DELISTED
Akero Therapeutics
AKRO
$37K ﹤0.01%
1,691
+374
+28% +$7.74K
DYAI icon
3932
Dyadic International
DYAI
$35.3M
$37K ﹤0.01%
+7,162
New +$42.9K
HEPA
3933
DELISTED
Hepion Pharmaceuticals
HEPA
$37K ﹤0.01%
+7
New +$27.1K
MSC
3934
Studio City International Holdings
MSC
$327M
$37K ﹤0.01%
1,879
-1,916
-50% -$37.3K
OESX icon
3935
Orion Energy Systems
OESX
$65.1M
$37K ﹤0.01%
1,112
+482
+77% +$14.5K
RPAY icon
3936
Repay Holdings
RPAY
$331M
$37K ﹤0.01%
2,585
-353
-12% -$4.93K
SBE.WS
3937
CALL
DELISTED
Switchback Energy Acquisition Corporation Warrants, exercisable for one share of Class A Common Stoc
SBE.WS
$37K ﹤0.01%
+62,300
New +$45.2K
ATLC icon
3938
Atlanticus Holdings
ATLC
$1.68B
$36K ﹤0.01%
4,104
BIIB icon
3939
CALL
Biogen
BIIB
$30.5B
$36K ﹤0.01%
124
PRQR icon
3940
ProQR Therapeutics
PRQR
$278M
$36K ﹤0.01%
3,645
-34,338
-90% -$267K
XBIO icon
3941
Xenetic Biosciences
XBIO
$6.78M
$36K ﹤0.01%
+2,544
New +$32.3K
XIN
3942
DELISTED
Xinyuan Real Estate
XIN
$36K ﹤0.01%
963
-153
-14% -$6.03K
USX
3943
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$36K ﹤0.01%
7,254
+1,019
+16% +$4.96K
PRGX
3944
DELISTED
PRGX Global, Inc.
PRGX
$36K ﹤0.01%
7,502
+1,124
+18% +$5.45K
ACNT icon
3945
Ascent Industries
ACNT
$141M
$35K ﹤0.01%
2,767
+477
+21% +$6.63K
STEX
3946
Streamex Corp
STEX
$75.6M
$35K ﹤0.01%
604
+138
+30% +$9.33K
CODI icon
3947
Compass Diversified
CODI
$816M
$35K ﹤0.01%
1,423
-14,637
-91% -$323K
LOOP icon
3948
Loop Industries
LOOP
$33.2M
$35K ﹤0.01%
3,579
-3,668
-51% -$39.5K
NVAX icon
3949
Novavax
NVAX
$1.27B
$35K ﹤0.01%
9,096
+2,845
+46% +$12.3K
TTNP
3950
DELISTED
Titan Pharmaceuticals
TTNP
$35K ﹤0.01%
+306
New +$36.9K

Similar funds

Deutsche Bank's Q4 2019 Portfolio in Review

As of Q4 2019, Deutsche Bank held 5,318 positions worth $153B, up 6.6% from $144B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Deutsche Bank withdrew a net $5.3B in Q4 2019, closing 262 positions and reducing 1,924 holdings. Its most notable exit was Celgene Corp, an estimated $273M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Deutsche Bank opened a new position in XP worth $32.9M.

  • Deutsche Bank's largest Q4 2019 buy was XP: 853,950 shares worth $32.9M.
  • Deutsche Bank added most to Johnson & Johnson in Q4 2019, an estimated $333M increase.
  • Deutsche Bank's biggest Q4 2019 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $780M.
  • Deutsche Bank fully exited Celgene Corp in Q4 2019, selling an estimated $273M.
  • Deutsche Bank's ten largest holdings make up 17% of its $153B portfolio in Q4 2019.
  • Deutsche Bank opened 407 new positions and closed 262 in Q4 2019.
  • Deutsche Bank's portfolio value rose 6.6% quarter-over-quarter to $153B.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.